{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:25:41Z","timestamp":1779297941287,"version":"3.51.4"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Anti-vascular endothelial growth factor (anti-VEGF) treatment are now widely used in patients with circumscribed choroidal hemangioma (CCH), however the concentrations of VEGF and other cytokines in CCH patients have not been known before. The study was conducted to compare various cytokine concentrations in the aqueous humor of eyes with CCH and control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 16 eyes of 16 patients with CCH, and 15 eyes of 15 patients with cataract as the control group were examined. Aqueous humor samples were assessed for 30 angiogenic and inflammatory cytokines by Luminex bead-based multiplex array.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Significantly, compared with control group, higher concentrations of VEGF-A and IP-10 were found in the CCH patients (P = 0.002 and P &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>VEGF-A and IP-10 might be involved with the angiogenic and antiangiogenic process in CCH patients, which provides new insight into the pathophysiology of CCH and could be potential targets for treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.916789","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T05:33:38Z","timestamp":1656394418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Cytokine Concentrations in Aqueous Humor of Eyes With Circumscribed Choroidal Hemangioma"],"prefix":"10.3389","volume":"13","author":[{"given":"Kailin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(01)00812-0","article-title":"Circumscribed Choroidal Hemangioma: Clinical Manifestations and Factors Predictive of Visual Outcome in 200 Consecutive Cases","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2036_19","article-title":"Circumscribed Choroidal Hemangioma: An Overview of Clinical Manifestation, Diagnosis and Management","volume":"67","author":"Sen","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14409","article-title":"High Recurrence Rate in Patients With Choroidal Hemangioma Treated With Limited Single Spot Photodynamic Therapy During Long-Term Follow-Up","volume":"98","author":"Stehouwer","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/Iae.0000000000001967","article-title":"Efficacy of Double Dose Photodynamic Therapy for Circumscribed Choroidal Hemangioma","volume":"39","author":"Lee","year":"2019","journal-title":"Retina J Retinal Vitreous Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20040701-04","article-title":"Anatomic and Visual Acuity Outcomes Following Thermal Laser Photocoagulation or Photodynamic Therapy for Symptomatic Circumscribed Choroidal Hemangioma With Associated Serous Retinal Detachment","volume":"35","author":"Scott","year":"2004","journal-title":"Ophthal Surg Las Im"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12810","article-title":"Transpupillary Thermotherapy as a Primary Treatment for Circumscribed Choroidal Haemangioma","volume":"94","author":"Cennamo","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31818bccfb","article-title":"Long-Term Results of Low-Dose Proton Beam Therapy for Circumscribed Choroidal Hemangiomas","volume":"29","author":"Levy-Gabriel","year":"2009","journal-title":"Retina J Retinal Vitreous Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.08.138","article-title":"Gamma Knife Radiosurgery for Choroidal Hemangioma: A Single-Institute Series","volume":"133","author":"Chung","year":"2020","journal-title":"World Neurosurg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2020.03.09","article-title":"High-Dose Ruthenium-106 Plaque Therapy for Circumscribed Choroidal Hemangioma: A Retrospective Study of 25 Chinese Patients","volume":"13","author":"Li","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2009.23.2.127","article-title":"Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma","volume":"23","author":"Sagong","year":"2009","journal-title":"Korean J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.81051","article-title":"Intravitreal Bevacizumab (Avastin) for Circumscribed Choroidal Hemangioma","volume":"59","author":"Mandal","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000505753","article-title":"Effectiveness and Safety of Intravitreal Injection of Conbercept as an Initial Treatment for Exudative Circumscribed Choroidal Hemangioma","volume":"243","author":"Lai","year":"2020","journal-title":"Ophthalmologica"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13151","article-title":"Differences in Aqueous Concentrations of Cytokines in Paediatric and Adult Patients With Coats' Disease","volume":"95","author":"Feng","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702782","article-title":"Treatment of a Vasoproliferative Tumour With Intravitreal Bevacizumab (Avastin)","volume":"21","author":"Kenawy","year":"2007","journal-title":"Eye (Lond)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702896","article-title":"Combined Treatment of a Juxtapapillary Retinal Capillary Haemangioma With Intravitreal Bevacizumab and Photodynamic Therapy","volume":"21","author":"Ziemssen","year":"2007","journal-title":"Eye (Lond)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/Nejm199802123380706","article-title":"Chemokines - Chemotactic Cytokines That Mediate Inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.1.155","article-title":"Human Interferon-Inducible Protein-10 Is a Potent Inhibitor of Angiogenesis in-Vivo","volume":"182","author":"Angiolillo","year":"1995","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.03.038","article-title":"Interferon Gamma-Inducible Protein 10 Selectively Inhibits Proliferation and Induces Apoptosis in Endothelial Cells","volume":"13","author":"Feldman","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000209968.66606.10","article-title":"IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain","volume":"98","author":"Bodnar","year":"2006","journal-title":"Circ Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000365487","article-title":"Aqueous Humor Cytokine Levels in Patients With Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration","volume":"53","author":"Sakurada","year":"2015","journal-title":"Ophthal Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-3910","article-title":"Interferon Gamma-Inducible Protein-10 (IP-10) and Eotaxin as Biomarkers in Age-Related Macular Degeneration","volume":"51","author":"Mo","year":"2010","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10123","article-title":"Cytokines and Chemokines in the Vitreous Fluid of Eyes With Uveal Melanoma","volume":"53","author":"Nagarkatti-Gude","year":"2012","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000475603","article-title":"Aqueous Humor Levels of Soluble Vascular Endothelial Growth Factor Receptor and Inflammatory Factors in Diabetic Macular Edema","volume":"238","author":"Noma","year":"2017","journal-title":"Ophthalmol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.916789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T05:33:40Z","timestamp":1656394420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.916789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":23,"alternative-id":["10.3389\/fendo.2022.916789"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.916789","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"article-number":"916789"}}